Ouimette Mike's Form 4 filing
Pliant Therapeutics, Inc. (PLRX) · filed Apr 3, 2023
- Accession no.
- 0001209191-23-022376
- Filed
- Apr 3, 2023
- Trade date
- Mar 30-Apr 3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $206.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ouimette MikeCIK 0001822619 | Officer (General Counsel & Corp. Sec'y) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 | Common Stock | SSaleDisposed | −4,874 | $26.52 | −$129,258.48 | 53,666 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −2,677 | $26.74 | −$71,582.98 | 50,989 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −200 | $27.46 | −$5,492 | 50,789 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.